Related Experiment Video
Updated: Jul 2, 2026

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
Published on: September 25, 2017
Development of differential cytotoxic compounds containing nitrosourea and benzothiazine nucleus
Abstract:
The in vivo activity of 4 new benzothiazinyl-nitrosourea compounds was investigated against Sarcoma-180 (S-180) and Ehrlich Ascitic Carcinoma (EAC) induced ascitic and solid tumors. EAC solid tumor was found to be the most sensitive, where one compound (no 4) inhibited tumor growth to only 3 per cent of the control value. All the 4 compounds tested were found to be toxicologically more selective than 5-fluorouracil and 6-mercaptopurine drugs. The reason for this selective toxicity may be attributed to the inhibition of isocyanate moiety in these compounds which causes toxicity to normal cells via a carbamoylation reaction. However, they may still remain potent, since they decompose into an alkylating carbonium species and a charge transfer complex which may interact with DNA via alkylation and intercalation reactions, respectively.
Insights
Four new benzothiazinyl-nitrosourea compounds showed potent anticancer activity against Ehrlich Ascitic Carcinoma (EAC) solid tumors. These novel compounds demonstrated superior toxicological selectivity compared to existing chemotherapy drugs.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Cancer Research
Background:
- Nitrosourea compounds are a class of anticancer agents.
- Developing novel anticancer drugs with improved selectivity is crucial.
Purpose of the Study:
- To evaluate the in vivo anticancer activity of four novel benzothiazinyl-nitrosourea compounds.
- To compare the efficacy and toxicity of these compounds against established chemotherapy drugs.
Main Methods:
- In vivo assessment of compound activity against Sarcoma-180 (S-180) and Ehrlich Ascitic Carcinoma (EAC) tumor models.
- Toxicological evaluation and comparison with 5-fluorouracil and 6-mercaptopurine.
Main Results:
- One compound (no. 4) significantly inhibited EAC solid tumor growth to 3% of control.
- All tested compounds exhibited greater toxicological selectivity than 5-fluorouracil and 6-mercaptopurine.
- Compounds showed potential for DNA interaction via alkylation and intercalation.
Conclusions:
- Benzothiazinyl-nitrosourea compounds represent a promising new class of anticancer agents.
- The selective toxicity may stem from inhibited carbamoylation, preserving potency through DNA-reactive decomposition products.
More Related Videos
Related Concept Videos
Electrophilic Aromatic Substitution: Nitration of Benzene
Nucleophilic Aromatic Substitution of Aryldiazonium Salts: Aromatic SN1
In the Sandmeyer reaction, for example, the diazonio group is replaced by a chloro, bromo, or cyano...
Preparation of Amines: Reduction of Oximes and Nitro Compounds
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
2° Amines to N-Nitrosamines: Reaction with NaNO2
Diazonium Group Substitution: –OH and –H
Physical Properties of Amines

